Mirati Therapeutics Investor Relations Material

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer. The company's portfolio consists of several product candidates meant to treat for example various hematologic cancers, including leukemia. The company cooperates with other medical companies to develop their products.